Form 4: Elevance Health Director Susan D. DeVore Reports Acquisition of Deferred Stock Units

Director Susan D. DeVore reported the acquisition of deferred stock units in Elevance Health, Inc.

Summary

• On May 15, 2024, Susan D. DeVore, a director of Elevance Health, Inc., acquired 388 deferred stock units.
• These units were accrued under the company's Board of Directors Compensation Program.
• The deferred stock units will be payable in Elevance Health common stock upon the earlier of (a) five years from the grant date or (b) the date DeVore ceases to be a board member, unless a later date is designated.
• Following the transaction, DeVore beneficially owns 1,701 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral as it reflects a standard transaction related to director compensation. There are no indications of positive or negative implications for the company's performance.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common among publicly traded companies. It provides transparency regarding the alignment of director interests with shareholder value.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and alignment of interests.

Key Dates